OTSUKA PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.otsuka.co.jp
Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 2800
- Registration Number
- NCT00234065
- Locations
- 🇯🇵
Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
Dose-response Study of OPC-12759 Ophthalmic Suspension
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2014-02-28
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 290
- Registration Number
- NCT00234078
- Locations
- 🇯🇵
Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 122
- Registration Number
- NCT00234104
- Locations
- 🇯🇵
Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT00233363
- Locations
- 🇯🇵
Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 301
- Registration Number
- NCT00233389
- Locations
- 🇯🇵
Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
© Copyright 2024. All Rights Reserved by MedPath